1. Home
  2. NUCL vs CGEN Comparison

NUCL vs CGEN Comparison

Compare NUCL & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUCL

Eagle Nuclear Energy Corp. Common stock

N/A

Current Price

$5.13

Market Cap

175.1M

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.09

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUCL
CGEN
Founded
2023
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.1M
148.7M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
NUCL
CGEN
Price
$5.13
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
220.2K
328.9K
Earning Date
05-22-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$112.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$1.13
52 Week High
$6.35
$2.38

Technical Indicators

Market Signals
Indicator
NUCL
CGEN
Relative Strength Index (RSI) 42.47 52.79
Support Level $4.77 $1.41
Resistance Level $6.08 $2.35
Average True Range (ATR) 0.61 0.11
MACD -0.01 -0.02
Stochastic Oscillator 29.10 26.37

Price Performance

Historical Comparison
NUCL
CGEN

About NUCL Eagle Nuclear Energy Corp. Common stock

Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds the rights to the mineable, measured and indicated uranium deposit in the United States, referred to as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated 37.73 million pounds of near-surface uranium and the adjacent Cordex Zone Eagle's SMR technology. Eagle's mission is to supply uranium to the growing nuclear energy industry and play a role in the global transition to clean, reliable, and affordable energy.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: